Immunotherapy Monitoring
The development of methods to propagate immune T-cells, and in particular tumor specific T-cells from the patients with cancer, lead to an important breakthrough; the identification of MAGE-1,a melanoma-specific antigen that stimulates human T-cells in-vitro. With antigen specific T-cells as a reagents, it was possible to clone the MAGE-1 studies showed that the human immune system can respond tumor antigens, and the findings stimulated a productive effort to discover tumor antigens. The result is a long and still-growing list of antigens from a variety of tumor that could serve a variety of tumor’s that could serve as targets for treatment.
- Parameters for Immune Response
- Biomarker Development for Ipilimumab and Prostate Gvaxtreatment
- Development of Biomarkers for an Engineered Anti PDL1 Antibody MPDL3280A and Clinical Activity
- Microenvironment Screening Platform Captures Biological Responses of Cancer Therapeutics
- Radiotherapy and Chemotherapy with Dendritic Cell Immunotherapy in Glioblastoma Patients
Related Conference of Immunotherapy Monitoring
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
Immunotherapy Monitoring Conference Speakers
Recommended Sessions
- Antibody Therapy of Cancer
- Brain Tumors
- Cancer biomarkers
- Cancer clinical trials
- Cancer Immunology & Immunotherapy
- Cancer micro and immuno environment
- Cancer Research
- Cancer vaccines
- Combining Cancer Immunotherapies
- Engineered T-Cell Therapy
- Immune checkpoint inhibitors
- Immuno-Oncology studies
- Immunotherapy - Tumors
- Immunotherapy Monitoring
- Novel Approaches in Cancer & Tumor
- Tumor biology
- Tumor Immunogenicity
- Tumor Immunology
- Tumor immunotherapy research
- Tumor markers and drug targeting
- Tumorigenesis
- Tumors
Related Journals
Are you interested in
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)